Publications by authors named "Wolfram Samlowski"

Claim this Profile
U
Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil.
Axel Rivas, Wolfram Samlowski, Tara A McCannel

Cancers (Basel)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case report.
Ryan Falk, Wolfram Samlowski, Amin Hedayat

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of brain metastases in relation to outcome during first-line ipilimumab plus nivolumab therapy for metastatic melanoma in a community oncology practice.
Claire Victoria Ong, Wolfram Samlowski

J Neurooncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Toxicity of Cemiplimab Therapy for Advanced Cutaneous Squamous Cell Skin Cancer in a Community Oncology Practice.
Tina Fung, Wolfram Samlowski, Raul Meoz

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy.
Chalette Lambert-Swainston, Wolfram Samlowski, Brandon Reynolds, Amin Hedayat

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between survival and real-world recurrence-free survival or distant metastasis-free survival among patients with completely resected stage IIB or IIC melanoma.
Wolfram Samlowski, Michelle A Silver, Andriana Hohlbauch, Shujing Zhang, Mizuho Fukunaga-Kalabis

Melanoma Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of an Accelerated Treatment Algorithm for Patients Developing Diarrhea as a Complication of Ipilimumab-Based Cancer Immunotherapy in a Community Practice.
Clarice Ho, Wolfram Samlowski

Curr Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report.
Claire V Ong, Wolfram Samlowski

Front Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
Sandip P Patel, Megan Othus, Young Kwang Chae, Michael J Dennis, Sarah Gordon, Wolfram Samlowski

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Non-Overlapping Somatic Mutations in , , , or on the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melanoma.
Wolfram Samlowski

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series.
Raquel Wescott, Wolfram Samlowski

Curr Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series.
Mark Chang, Wolfram Samlowski, Raul Meoz

Oncotarget· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squamous cell skin cancer: a case series.
Mark Chang, Wolfram Samlowski, Raul Meoz

Oncotarget· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of Influence of Non-Overlapping Mutations in , , or on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma.
Alyssa Panning, Wolfram Samlowski, Gabriel Allred

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission.
Kaviyon Sadrolashrafi, Wolfram Samlowski

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.
Wolfram Samlowski, Nicholas J Robert, Liwei Chen, Brad Schenkel, Catherine Davis

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes of patients with stage IIB or IIC cutaneous melanoma treated at US community oncology clinics.
Wolfram Samlowski, Michelle A Silver, Andriana Hohlbauch, Shujing Zhang, Emilie Scherrer

Future Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elective Checkpoint Inhibitor Discontinuation in Metastatic Solid Tumor Patients: A Case Series.
Ruby Lopez-Flores, Wolfram Samlowski, Leanne Perez

Ann Case Rep· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Elective Checkpoint Inhibitor Discontinuation in Patients with Metastatic Melanoma Who Achieved a Complete Remission: Real-World Data.
Leanne Perez, Wolfram Samlowski, Ruby Lopez-Flores

Biomedicines· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hedgehog Inhibitor Induction with Addition of Concurrent Superficial Radiotherapy in Patients with Locally Advanced Basal Cell Carcinoma: A Case Series.
Joshua P Weissman, Wolfram Samlowski, Raul Meoz

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy.
Wolfram Samlowski, Camille Adajar

BMC Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of brain metastases after adjuvant therapy for high-risk melanoma.
Wolfram E Samlowski, James Moon, Merle Witter, Michael B Atkins, John M Kirkwood

Cancer Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional survival of metastatic renal cell carcinoma patients treated with high-dose interleukin-2.
David M Gill, David D Stenehjem, Kinjal Parikh, Joseph Merriman, Arun Sendilnathan, Wolfram E Samlowski

Ecancermedicalscience· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
David D Stenehjem, Michael Toole, Joseph Merriman, Kinjal Parikh, Stephanie Daignault, Wolfram E Samlowski

Cancer Immunol Immunother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
Carmen Ruiz, Julia Li, Madelyn S Luttgen, Anand Kolatkar, Jude T Kendall, Wolfram E Samlowski

Phys Biol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis